667
Views
28
CrossRef citations to date
0
Altmetric
Original Article

Prevalence of hepatitis C and pre-testing awareness of hepatitis C status in 1500 consecutive PWID participants at the Stockholm needle exchange program

, ORCID Icon, &
Pages 728-736 | Received 17 Feb 2017, Accepted 16 May 2017, Published online: 02 Jun 2017

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (6)

Martin Kåberg, Niklas Karlsson, Andrea Discacciati, Katarina Widgren, Ola Weiland, Anna Mia Ekström & Anders Hammarberg. (2020) Significant decrease in injection risk behaviours among participants in a needle exchange programme. Infectious Diseases 52:5, pages 336-346.
Read now
Martin Kåberg, Simon B. Larsson, Anna Jerkeman, Anders Nystedt, Ann-Sofi Duberg, Jan Kövamees, Magdalena Ydreborg, Soo Aleman, Katharina Büsch, Marianne Alanko Blomé, Ola Weiland & Jonas Söderholm. (2020) High risk of non-alcoholic liver disease mortality in patients with chronic hepatitis C with illicit substance use disorder. Scandinavian Journal of Gastroenterology 55:5, pages 574-580.
Read now
Bruno Ali Lopez Luis, Katia Lorena Moyado-Ocampo & Luis Enrique Soto-Ramírez. (2020) Hospital-based hepatitis C screening in a tertiary care centre in Mexico: targeted at health care-associated transmission. Infectious Diseases 52:2, pages 139-141.
Read now
Martin Kåberg, Erika Edgren, Anders Hammarberg & Ola Weiland. (2019) Hepatitis C virus (HCV) related liver fibrosis in people who inject drugs (PWID) at the Stockholm Needle Exchange – evaluated with liver elasticity. Scandinavian Journal of Gastroenterology 54:3, pages 319-327.
Read now
Braira Wahid, Komal Saleem, Nouman Rasool, Shazia Rafique, Amjad Ali, Muhammad Waqar & Muhammad Idrees. (2018) Tattooing trend: major cause of HCV transmission among youngsters. Infectious Diseases 50:11-12, pages 871-873.
Read now

Articles from other publishers (22)

Moa Andresen Bergström, Maria E. Andersson & Simon B. Larsson. (2023) Detection of drugs and hepatitis C virus in used syringes from a needle exchange in Gothenburg, Sweden. Drug Testing and Analysis.
Crossref
E. Kågström, A. Lannergård, J. El Khosht, P. Lörelius, J. Månflod & S. Strömdahl. (2023) Prevalence, risk factors, treatment uptake and treatment outcome of hepatitis C virus in people who inject drugs at the needle and syringe program in Uppsala, Sweden. Harm Reduction Journal 20:1.
Crossref
Suzan M. Walters, David Frank, Marisa Felsher, Jessica Jaiswal, Scott Fletcher, Alex S. Bennett, Samuel R. Friedman, Lawrence J. Ouellet, Danielle C. Ompad, Wiley Jenkins & Mai T. Pho. (2023) How the rural risk environment underpins hepatitis C risk: Qualitative findings from rural southern Illinois, United States. International Journal of Drug Policy 112, pages 103930.
Crossref
Martin Kåberg, Sofie Larsson, Jakob Bergström & Anders Hammarberg. (2022) Quality-adjusted life years among people who inject drugs in a needle syringe program in Sweden. Quality of Life Research 32:1, pages 197-207.
Crossref
Anna Conway, Phillip Read, Rosie Gilliver, Tony McNaughton, Heather Valerio, Evan Cunningham, Charles Henderson, Brett Hadlow, Katrina Molloy, Anna Doab, Shane Tillakeratne, Lucy Pepolim, Mary Harrod, Gregory Dore & Jason Grebely. (2022) Awareness of HCV Status and Preferences for Testing and Treatment among People with Recent Injecting Drug Use at a Peer-Led Needle and Syringe Program: The TEMPO Pilot Study. Viruses 14:11, pages 2463.
Crossref
José Carlos Fernández de Cañete Camacho, Antonio Mancebo Martínez, María Adela García Mena & José María Moreno Planas. (2022) Influencia de los trastornos psiquiátricos y la terapia de sustitución con opiáceos en el tratamiento del virus de la hepatitis c con antivirales de acción directa en usuarios de drogas por vía parenteral. Gastroenterología y Hepatología 45:4, pages 265-273.
Crossref
José Carlos Fernández de Cañete Camacho, Antonio Mancebo Martínez, María Adela García Mena & José María Moreno Planas. (2022) Influence of psychiatric disorders and opioid substitution therapy on hepatitis C treatment with direct-acting antivirals in people who inject drugs. Gastroenterología y Hepatología (English Edition) 45:4, pages 265-273.
Crossref
K. Lindqvist, C. Wallmofeldt, E. Holmén, A. Hammarberg & M. Kåberg. (2021) Health literacy and changes in pattern of drug use among participants at the Stockholm Needle Exchange Program during the COVID-19 pandemic. Harm Reduction Journal 18:1.
Crossref
Marisa Felsher, Karin E. Tobin, Mark Sulkowski, Carl Latkin & Oluwaseun Falade-Nwulia. (2021) HCV communication within ego-centric networks of men and women who inject drugs. Drug and Alcohol Dependence 229, pages 109157.
Crossref
Daisy Gibbs, Jason Grebely, Rachel Sutherland, Sarah Larney, Kerryn Butler, Paul M. Dietze, Mitchell Starr & Amy Peacock. (2021) Concordance between self‐reported and current hepatitis C virus infection status in a sample of people who inject drugs in Sydney and Canberra, Australia. Drug and Alcohol Review 40:7, pages 1349-1353.
Crossref
Caroline Gahrton, Anders Håkansson, Martin Kåberg, Anna Jerkeman, Henrike Häbel, Olav Dalgard, Ann-Sofi Duberg & Soo Aleman. (2021) Mortality among amphetamine users with hepatitis C virus infection: A nationwide study. PLOS ONE 16:6, pages e0253710.
Crossref
Niklas Karlsson, Martin Kåberg, Torsten Berglund, Anders Hammarberg, Linnea Widman & Anna Mia Ekström. (2021) A prospective cohort study of risk behaviours, retention and loss to follow-up over 5 years among women and men in a needle exchange program in Stockholm, Sweden. International Journal of Drug Policy 90, pages 103059.
Crossref
Raisa Hannula, Jonas Söderholm, Therese Svendsen, Maja Skaland, Svein A. Nordbø, Harald Steinum & Jan K. Damås. (2021) Hepatitis C outreach project and cross-sectional epidemiology in high-risk populations in Trondheim, Norway. Therapeutic Advances in Infectious Disease 8, pages 204993612110539.
Crossref
Malin Värmå Falk, Susanne Strömdahl, Anna Mia Ekström, Martin Kåberg, Niklas Karlsson, Helena Dahlborn & Anders Hammarberg. (2020) A qualitative study of facilitators and barriers to participate in a needle exchange program for women who inject drugs. Harm Reduction Journal 17:1.
Crossref
Roya Rashti, Heidar Sharafi, Seyed Moayed Alavian, Yousef Moradi, Amjad Mohamadi Bolbanabad & Ghobad Moradi. (2020) Systematic Review and Meta-Analysis of Global Prevalence of HBsAg and HIV and HCV Antibodies among People Who Inject Drugs and Female Sex Workers. Pathogens 9:6, pages 432.
Crossref
Theresa Stocks, Leah J. Martin, Sharon Kühlmann-Berenzon & Tom Britton. (2020) Dynamic modeling of hepatitis C transmission among people who inject drugs. Epidemics 30, pages 100378.
Crossref
Caroline Gahrton, Gabriel Westman, Karin Lindahl, Fredrik Öhrn, Olav Dalgard, Christer Lidman, Lars-Håkan Nilsson, Karouk Said, Ann-Sofi Duberg & Soo Aleman. (2019) Prevalence of Viremic hepatitis C, hepatitis B, and HIV infection, and vaccination status among prisoners in Stockholm County. BMC Infectious Diseases 19:1.
Crossref
Ru Han, Junwen Zhou, Clément François & Mondher Toumi. (2019) Prevalence of hepatitis C infection among the general population and high-risk groups in the EU/EEA: a systematic review update. BMC Infectious Diseases 19:1.
Crossref
Verónica Saludes, Adrián Antuori, Cinta Folch, Noemí González, Núria Ibáñez, Xavier Majó, Joan Colom, Lurdes Matas, Jordi Casabona & Elisa Martró. (2019) Utility of a one-step screening and diagnosis strategy for viremic HCV infection among people who inject drugs in Catalonia. International Journal of Drug Policy 74, pages 236-245.
Crossref
Andrea Lombardi & Mario U. Mondelli. (2019) Hepatitis C: Is eradication possible?. Liver International 39:3, pages 416-426.
Crossref
Martin Kåberg, Georg Navér, Anders Hammarberg & Ola Weiland. (2018) Incidence and spontaneous clearance of hepatitis C virus (HCV) in people who inject drugs at the Stockholm Needle Exchange-Importance for HCV elimination. Journal of Viral Hepatitis 25:12, pages 1452-1461.
Crossref
Tanya L. Applegate, Emmanuel Fajardo & Jilian A. Sacks. (2018) Hepatitis C Virus Diagnosis and the Holy Grail. Infectious Disease Clinics of North America 32:2, pages 425-445.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.